Neuropathic pain: targeting the melatonin MT<sub>2</sub> receptor
Neuropathic pain affects a large proportion of the population and reduces a person’s ability to perform optimally. In South Africa, there are a host of factors that hinder the correct diagnosis and treatment of neuropathic pain. Patients suffering from neuropathic pain are treated suboptimally with...
Guardado en:
Autores principales: | N. Smith, H. Ismail, N. Schellack |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
AOSIS
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/050c4c36cf34433d875f8f064600d765 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ocular Neuropathic Pain: An Overview Focusing on Ocular Surface Pains
por: Ebrahimiadib N, et al.
Publicado: (2020) -
Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
por: Coluzzi F, et al.
Publicado: (2020) -
Intrathecal interleukin-1β decreases sigma-1 receptor expression in spinal astrocytes in a murine model of neuropathic pain
por: Sheu-Ran Choi, et al.
Publicado: (2021) -
Exercise for Neuropathic Pain: A Systematic Review and Expert Consensus
por: Yong-Hui Zhang, et al.
Publicado: (2021) -
The Validity and Reliability of a New Modified Persian Version of DN4 to Discriminate Non-neuropathic from Neuropathic
por: Seyed Pezhman Madani, et al.
Publicado: (2021)